Ibrilatazar

Chemical compound

Summary

Ibrilatazar also known as α-hydroxylinoleic acid is a small-molecule, experimental cancer drug being developed by Ability Pharmaceuticals.

Originally created by Edgar181

10/28/2019, 2:11:30 PM

Modified

12/26/2025, 9:01:06 PM